Aptose Biosciences (TSE:APS) Sets New 1-Year Low at $1.00

Aptose Biosciences Inc. (TSE:APSGet Free Report) (NASDAQ:APTO)’s share price reached a new 52-week low on Monday . The company traded as low as C$1.00 and last traded at C$1.00, with a volume of 1295 shares trading hands. The stock had previously closed at C$1.03.

Aptose Biosciences Stock Up 1.0 %

The stock’s 50-day moving average price is C$1.34 and its two-hundred day moving average price is C$2.04. The stock has a market capitalization of C$16.47 million, a P/E ratio of -0.10 and a beta of 1.47. The company has a current ratio of 0.78, a quick ratio of 5.41 and a debt-to-equity ratio of 14.27.

Aptose Biosciences (TSE:APSGet Free Report) (NASDAQ:APTO) last released its earnings results on Tuesday, May 14th. The biotechnology company reported C($0.98) earnings per share for the quarter, beating analysts’ consensus estimates of C($1.12) by C$0.14. As a group, research analysts expect that Aptose Biosciences Inc. will post -0.59 earnings per share for the current fiscal year.

Aptose Biosciences Company Profile

(Get Free Report)

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.

Recommended Stories

Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.